BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22415585)

  • 1. Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.
    Pritchard-Jones K; Moroz V; Vujanić G; Powis M; Walker J; Messahel B; Hobson R; Levitt G; Kelsey A; Mitchell C
    Ann Oncol; 2012 Sep; 23(9):2457-2463. PubMed ID: 22415585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
    Irtan S; Messahel B; Moroz V; Taylor RE; Grundy R; Kelsey A; Vujanic G; Pritchard-Jones K;
    Radiother Oncol; 2019 Feb; 131():1-7. PubMed ID: 30773174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
    Zekri W; Yacoub DM; Ibrahim A; Madney Y
    J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
    Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
    Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
    Salama A; Kamel A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020).
    Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K;
    Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.
    Powis M; Messahel B; Hobson R; Gornall P; Walker J; Pritchard-Jones K
    J Pediatr Surg; 2013 Nov; 48(11):2181-6. PubMed ID: 24210183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
    Nicolin G; Taylor R; Baughan C; Shannon R; Stevens S; Richardson D; Kelsey A; Pritchard-Jones K; Mitchell C
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):175-80. PubMed ID: 17980506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience.
    Irtan S; Jitlal M; Bate J; Powis M; Vujanic G; Kelsey A; Walker J; Mitchell C; Machin D; Pritchard-Jones K;
    Eur J Cancer; 2015 Jan; 51(2):225-32. PubMed ID: 25465191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
    Elayadi M; Magdy S; Khalil E; Zekri W
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy for adult Wilms' tumour: an experience from one centre.
    Li JJ; Huang HH; Shen J; Jiang JY; Pan F; Yu ST; Kang Y; Zhao XX; Yan XC; Liang HJ
    Clin Transl Oncol; 2011 Sep; 13(9):672-6. PubMed ID: 21865139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, clinical features and treatment outcome of Wilms' tumor in Taiwan: a report from Taiwan Pediatric Oncology Group.
    Hung IJ; Chang WH; Yang CP; Jaing TH; Liang DC; Lin KH; Lin DT; Hsiao CC; Hsieh YL; Chen JS; Chang TT; Peng CT; Shu SG; Lin MT; Chen BW; Lin KS;
    J Formos Med Assoc; 2004 Feb; 103(2):104-11. PubMed ID: 15083240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.